Peptide Half-Life Tracking
Published Apr 20, 2026 · 6 minute read
Half-life formulas, accumulation, steady-state estimates, and tracking limits in plain language.
Key Takeaways
- Half-life tracking uses reference decay math to visualize logged entries over time.
- Accumulation and steady-state views are mathematical estimates, not measured blood concentrations.
- Peptide Tracker uses half-life curves to provide visual context beside your dose history.
1. What Half-Life Means When Tracking
Half-life is the time it takes for a modeled amount of a compound to fall by 50%. If a peptide has a 24-hour half-life in your tracking reference, the model estimates that one half of the logged amount remains after 24 hours, one quarter remains after 48 hours, one eighth remains after 72 hours, and so on.
That does not mean the compound suddenly turns off at one exact time. Half-life describes a curve, not a switch. A tracker uses that curve to estimate relative amount over time, show overlap between doses, and make timing patterns easier to see.
Useful terms: half-life means time to 50% remaining; decay means the modeled decline after a dose; accumulation means overlap from repeated doses; steady state means a repeating peak-and-trough pattern under a consistent schedule.
2. The Half-Life Formula
The common first-order half-life model uses exponential decay. The remaining amount at a future time is based on the starting amount, elapsed time, and half-life.
Single-dose decay
The standard half-life form is:
Single-dose decay
The standard half-life form is:
C(t) = C0 × (0.5)t / t1/2
C(t) = modeled amount remaining at time t.
C0 = initial logged amount.
t = elapsed time.
t1/2 = half-life.
The equivalent exponential form is C(t) = C0e-kt, where k = ln(2) / t1/2. The two forms describe the same model; the half-life version is usually easier to read for tracking.
For tracking, the units just need to be consistent. If the dose is in mg, the remaining modeled amount is in mg. If elapsed time is measured in hours, half-life should also be in hours. If elapsed time is measured in days, half-life should also be in days.
After one half-life, 50% remains. After two half-lives, 25% remains. After three half-lives, 12.5% remains. After five half-lives, about 3.1% remains. The model keeps declining; it does not become literal zero at a fixed time.
3. Real-World Example: Semaglutide Half-Life
Suppose a logged 1 mg dose of Semaglutide. Semaglutide has an elimination half-life of approximately 165 hours (about 1 week or 7 days)[1]. This long half-life is part of why labeled semaglutide products can use once-weekly dosing.[2]
| Elapsed time | Calculation | Remaining | % remaining |
|---|---|---|---|
| 0 hours | initial log | 1.00 mg | 100% |
| 165h (1 wk) | 1 mg × (0.5)165 / 165 | 0.50 mg | 50% |
| 330h (2 wks) | 1 mg × (0.5)330 / 165 | 0.25 mg | 25% |
| 495h (3 wks) | 1 mg × (0.5)495 / 165 | 0.125 mg | 12.5% |
Example model only: the line passes through each table point. It shows the reference decay curve for a logged 1 mg semaglutide dose.
Because the half-life (165 hours) is roughly the same as the typical dosing interval (once weekly / 168 hours), significant accumulation occurs. When taking a second weekly dose, about 50% of the first dose is still modeled to be in the system. The model indicates steady-state exposure is achieved after 4 to 5 weeks.
For tracking semaglutide specifically, check out our semaglutide tracker app guide. For broader GLP-1 logging, see the GLP-1 tracker app guide.
A half-life model is most useful as a consistency tool. It helps you visualize what was logged, when it was logged, and how a reference decay curve changes between logs.
4. Accumulation and Overlap
When multiple doses are logged, a tracker calculates each dose as its own decay curve, then adds the remaining modeled amounts together at each point in time. This is why the total modeled amount can rise after a new log while still carrying a remainder from earlier logs.
Each logged dose contributes less over time, and the total is the combined remainder from all previous entries. This is a bookkeeping model, not a lab measurement.
With a repeated schedule, the curve may eventually settle into a pattern where each new peak and next trough are similar to the previous cycle. In simplified first-order models, this is described as steady state. Many educational references use about four to five half-lives as a rough time frame for approaching steady state, but real-world interpretation depends on the compound, person, formulation, and clinical context.
Keep in mind: A modeled curve is a visual estimate based on logged amounts and reference half-lives, not a personalized pharmacokinetic analysis.
Tirzepatide has a slightly different reference half-life pattern than semaglutide. You can learn more in our tirzepatide tracker app guide.
5. Why Half-Life Tracking Helps
Half-life tracking makes a log more readable by turning separate dose entries into a continuous timeline. Instead of only seeing a list of dates and amounts, you can see how close logs were to each other, whether gaps were longer than usual, and how a schedule creates peaks and troughs.
- Compare logged timing against a planned daily, weekly, or interval schedule.
- See estimated overlap when doses are close together.
- Understand why long half-life references create smoother curves.
- Prepare clearer records for conversations with a clinician or pharmacist.
The model is only as good as the inputs. Incorrect dose amount, unit, time, compound selection, or half-life reference can create misleading output. Keep the log accurate to get the most useful visualizations.
6. Common Mistakes
- Mixing hours and days in the same formula.
- Assuming a half-life estimate can predict exact blood concentration.
- Using a half-life estimate from one compound, salt form, or formulation for another.
- Treating “five half-lives” as a hard medical clearance rule.
- Changing dose timing based only on modeled output instead of qualified guidance.
7. How Peptide Tracker Uses This Concept
Peptide Tracker is built for private logging and visualization. The app can store dose history, schedule reminders, track inventory, and display half-life curves for supported compounds and custom entries. The goal is to help you maintain a clearer record.
Use the half-life visualizer as a reference layer next to your log. For clinical interpretation, dose changes, missed doses, or questions about what a curve means for your care, always talk with a qualified healthcare professional.
8. Half-Life Tracking FAQ
What is the half-life of Semaglutide?
The DailyMed prescribing label for WEGOVY describes semaglutide as having an elimination half-life of approximately 1 week. Other clinical pharmacokinetic references commonly express that as about 165 hours. Treat this as a reference value for tracking math.
When does Semaglutide reach steady state?
Using the DailyMed label's approximate 1-week elimination half-life as the reference, a simple tracking model usually approaches a repeating peak-and-trough pattern after about 4 to 5 half-lives, or roughly 4 to 5 weeks.
Does half-life tell me when a peptide is completely gone?
No. In the exponential model, the remaining amount keeps getting smaller but does not hit literal zero. Trackers often show practical decline, not complete disappearance.
Can I compare two compounds by half-life alone?
Half-life is only one reference value. Dose amount, schedule, route, formulation, biology, and clinical context matter. A tracker can visualize timing, but it cannot replace professional interpretation.
Why does the same schedule look different for different compounds?
A longer half-life generally creates more overlap between logs, while a shorter half-life creates sharper rises and falls. That visual difference comes from the decay formula.